Nasal spray drug related to ketamine approved by FDA to treat depression

Pluralism / Mar 06, 2019 - Source: nbcnews

The U.S. Food and Drug Administration on Tuesday approved esketamine, an experimental nasal spray that delivers the active ingredients of the “club drug” ketamine, as a new treatment for severe depression. The Johnson & Johnson nasal spray is a ...

Read full story >>

Ακολούθησε το pluralism.gr στο Instagram για αποκλειστικό περιεχόμενο!